Chargement en cours...
A targeted extracorporeal therapy for endotoxemia: the time has come
Endotoxemia, whether primary (due to Gram-negative infection) or secondary (due to epithelial barrier dysfunction), appears to be extremely common in the critically ill and injured. High levels of endotoxin activity are associated with worse clinical outcomes. In Japan, polymyxin B hemoperfusion has...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2007
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2206410/ https://ncbi.nlm.nih.gov/pubmed/17567925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc5918 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|